nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—ACHE—kidney cancer	0.368	0.63	CbGaD
Galantamine—BCHE—kidney cancer	0.217	0.37	CbGaD
Galantamine—CYP2D6—Temsirolimus—kidney cancer	0.0278	0.169	CbGbCtD
Galantamine—CYP3A4—Everolimus—kidney cancer	0.0262	0.159	CbGbCtD
Galantamine—CYP3A4—Temsirolimus—kidney cancer	0.0177	0.108	CbGbCtD
Galantamine—CYP2D6—Pazopanib—kidney cancer	0.0146	0.0889	CbGbCtD
Galantamine—CYP2D6—Erlotinib—kidney cancer	0.0104	0.0635	CbGbCtD
Galantamine—CYP3A4—Pazopanib—kidney cancer	0.0093	0.0566	CbGbCtD
Galantamine—CYP2D6—Sorafenib—kidney cancer	0.00849	0.0516	CbGbCtD
Galantamine—CYP2D6—Vinblastine—kidney cancer	0.00838	0.051	CbGbCtD
Galantamine—CYP3A4—Erlotinib—kidney cancer	0.00664	0.0404	CbGbCtD
Galantamine—CYP3A4—Paclitaxel—kidney cancer	0.00608	0.0369	CbGbCtD
Galantamine—CYP3A4—Sorafenib—kidney cancer	0.0054	0.0328	CbGbCtD
Galantamine—CYP3A4—Vinblastine—kidney cancer	0.00533	0.0324	CbGbCtD
Galantamine—CYP3A4—Vincristine—kidney cancer	0.00524	0.0319	CbGbCtD
Galantamine—CYP2D6—Doxorubicin—kidney cancer	0.00515	0.0313	CbGbCtD
Galantamine—CYP3A4—Sunitinib—kidney cancer	0.00437	0.0266	CbGbCtD
Galantamine—CYP3A4—Doxorubicin—kidney cancer	0.00327	0.0199	CbGbCtD
Galantamine—Tinnitus—Capecitabine—kidney cancer	0.000112	0.000557	CcSEcCtD
Galantamine—Loss of consciousness—Paclitaxel—kidney cancer	0.000112	0.000557	CcSEcCtD
Galantamine—Constipation—Vincristine—kidney cancer	0.000112	0.000557	CcSEcCtD
Galantamine—Pain in extremity—Doxorubicin—kidney cancer	0.000112	0.000557	CcSEcCtD
Galantamine—Paraesthesia—Gemcitabine—kidney cancer	0.000112	0.000555	CcSEcCtD
Galantamine—Flushing—Capecitabine—kidney cancer	0.000112	0.000555	CcSEcCtD
Galantamine—Cardiac disorder—Capecitabine—kidney cancer	0.000112	0.000555	CcSEcCtD
Galantamine—Cough—Paclitaxel—kidney cancer	0.000111	0.000553	CcSEcCtD
Galantamine—Asthenia—Sunitinib—kidney cancer	0.000111	0.000552	CcSEcCtD
Galantamine—Nausea—Vinblastine—kidney cancer	0.000111	0.00055	CcSEcCtD
Galantamine—Somnolence—Gemcitabine—kidney cancer	0.000111	0.000549	CcSEcCtD
Galantamine—Convulsion—Paclitaxel—kidney cancer	0.000111	0.000549	CcSEcCtD
Galantamine—Nausea—Everolimus—kidney cancer	0.00011	0.000548	CcSEcCtD
Galantamine—Diarrhoea—Sorafenib—kidney cancer	0.00011	0.000548	CcSEcCtD
Galantamine—Hypertension—Paclitaxel—kidney cancer	0.00011	0.000547	CcSEcCtD
Galantamine—Angiopathy—Capecitabine—kidney cancer	0.000109	0.000542	CcSEcCtD
Galantamine—Immune system disorder—Capecitabine—kidney cancer	0.000109	0.00054	CcSEcCtD
Galantamine—Chest pain—Paclitaxel—kidney cancer	0.000109	0.00054	CcSEcCtD
Galantamine—Myalgia—Paclitaxel—kidney cancer	0.000109	0.00054	CcSEcCtD
Galantamine—Arthralgia—Paclitaxel—kidney cancer	0.000109	0.00054	CcSEcCtD
Galantamine—Anxiety—Paclitaxel—kidney cancer	0.000108	0.000538	CcSEcCtD
Galantamine—Decreased appetite—Gemcitabine—kidney cancer	0.000108	0.000537	CcSEcCtD
Galantamine—Hypersensitivity—Dactinomycin—kidney cancer	0.000108	0.000537	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000108	0.000536	CcSEcCtD
Galantamine—Arrhythmia—Capecitabine—kidney cancer	0.000107	0.000534	CcSEcCtD
Galantamine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000107	0.000533	CcSEcCtD
Galantamine—Discomfort—Paclitaxel—kidney cancer	0.000107	0.000533	CcSEcCtD
Galantamine—Fatigue—Gemcitabine—kidney cancer	0.000107	0.000533	CcSEcCtD
Galantamine—Gastrointestinal pain—Vincristine—kidney cancer	0.000107	0.000533	CcSEcCtD
Galantamine—Dizziness—Sorafenib—kidney cancer	0.000106	0.000529	CcSEcCtD
Galantamine—Constipation—Gemcitabine—kidney cancer	0.000106	0.000528	CcSEcCtD
Galantamine—Nausea—Erlotinib—kidney cancer	0.000106	0.000528	CcSEcCtD
Galantamine—Dry mouth—Paclitaxel—kidney cancer	0.000106	0.000528	CcSEcCtD
Galantamine—Diarrhoea—Sunitinib—kidney cancer	0.000106	0.000527	CcSEcCtD
Galantamine—Ataxia—Doxorubicin—kidney cancer	0.000105	0.000524	CcSEcCtD
Galantamine—Mental disorder—Capecitabine—kidney cancer	0.000105	0.000524	CcSEcCtD
Galantamine—Asthenia—Dactinomycin—kidney cancer	0.000105	0.000523	CcSEcCtD
Galantamine—Confusional state—Paclitaxel—kidney cancer	0.000105	0.000522	CcSEcCtD
Galantamine—Malnutrition—Capecitabine—kidney cancer	0.000105	0.00052	CcSEcCtD
Galantamine—Dehydration—Doxorubicin—kidney cancer	0.000104	0.000518	CcSEcCtD
Galantamine—Abdominal pain—Vincristine—kidney cancer	0.000104	0.000515	CcSEcCtD
Galantamine—Body temperature increased—Vincristine—kidney cancer	0.000104	0.000515	CcSEcCtD
Galantamine—Flatulence—Capecitabine—kidney cancer	0.000103	0.000513	CcSEcCtD
Galantamine—Dysgeusia—Capecitabine—kidney cancer	0.000103	0.000509	CcSEcCtD
Galantamine—Dizziness—Sunitinib—kidney cancer	0.000102	0.000509	CcSEcCtD
Galantamine—Feeling abnormal—Gemcitabine—kidney cancer	0.000102	0.000509	CcSEcCtD
Galantamine—Shock—Paclitaxel—kidney cancer	0.000102	0.000509	CcSEcCtD
Galantamine—Vomiting—Sorafenib—kidney cancer	0.000102	0.000509	CcSEcCtD
Galantamine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000102	0.000509	CcSEcCtD
Galantamine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000102	0.000509	CcSEcCtD
Galantamine—Nervous system disorder—Paclitaxel—kidney cancer	0.000102	0.000507	CcSEcCtD
Galantamine—Hypokalaemia—Doxorubicin—kidney cancer	0.000102	0.000507	CcSEcCtD
Galantamine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000102	0.000507	CcSEcCtD
Galantamine—Tachycardia—Paclitaxel—kidney cancer	0.000102	0.000505	CcSEcCtD
Galantamine—Rash—Sorafenib—kidney cancer	0.000102	0.000505	CcSEcCtD
Galantamine—Dermatitis—Sorafenib—kidney cancer	0.000101	0.000504	CcSEcCtD
Galantamine—Back pain—Capecitabine—kidney cancer	0.000101	0.000503	CcSEcCtD
Galantamine—Skin disorder—Paclitaxel—kidney cancer	0.000101	0.000502	CcSEcCtD
Galantamine—Headache—Sorafenib—kidney cancer	0.000101	0.000501	CcSEcCtD
Galantamine—Muscle spasms—Capecitabine—kidney cancer	0.000101	0.0005	CcSEcCtD
Galantamine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000101	0.0005	CcSEcCtD
Galantamine—Diarrhoea—Dactinomycin—kidney cancer	0.0001	0.000499	CcSEcCtD
Galantamine—Anorexia—Paclitaxel—kidney cancer	9.92e-05	0.000493	CcSEcCtD
Galantamine—Gastritis—Doxorubicin—kidney cancer	9.92e-05	0.000493	CcSEcCtD
Galantamine—Muscular weakness—Doxorubicin—kidney cancer	9.88e-05	0.000491	CcSEcCtD
Galantamine—Vision blurred—Capecitabine—kidney cancer	9.87e-05	0.00049	CcSEcCtD
Galantamine—Vomiting—Sunitinib—kidney cancer	9.85e-05	0.00049	CcSEcCtD
Galantamine—Body temperature increased—Gemcitabine—kidney cancer	9.83e-05	0.000488	CcSEcCtD
Galantamine—Tremor—Capecitabine—kidney cancer	9.81e-05	0.000487	CcSEcCtD
Galantamine—Rash—Sunitinib—kidney cancer	9.77e-05	0.000486	CcSEcCtD
Galantamine—Dermatitis—Sunitinib—kidney cancer	9.76e-05	0.000485	CcSEcCtD
Galantamine—Hypotension—Paclitaxel—kidney cancer	9.73e-05	0.000483	CcSEcCtD
Galantamine—Ill-defined disorder—Capecitabine—kidney cancer	9.71e-05	0.000483	CcSEcCtD
Galantamine—Headache—Sunitinib—kidney cancer	9.71e-05	0.000482	CcSEcCtD
Galantamine—Dysphagia—Doxorubicin—kidney cancer	9.68e-05	0.000481	CcSEcCtD
Galantamine—Anaemia—Capecitabine—kidney cancer	9.68e-05	0.000481	CcSEcCtD
Galantamine—Hypersensitivity—Vincristine—kidney cancer	9.66e-05	0.00048	CcSEcCtD
Galantamine—Nausea—Sorafenib—kidney cancer	9.57e-05	0.000475	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	9.48e-05	0.000471	CcSEcCtD
Galantamine—Malaise—Capecitabine—kidney cancer	9.44e-05	0.000469	CcSEcCtD
Galantamine—Insomnia—Paclitaxel—kidney cancer	9.42e-05	0.000468	CcSEcCtD
Galantamine—Vertigo—Capecitabine—kidney cancer	9.4e-05	0.000467	CcSEcCtD
Galantamine—Asthenia—Vincristine—kidney cancer	9.4e-05	0.000467	CcSEcCtD
Galantamine—Syncope—Capecitabine—kidney cancer	9.39e-05	0.000466	CcSEcCtD
Galantamine—Paraesthesia—Paclitaxel—kidney cancer	9.35e-05	0.000465	CcSEcCtD
Galantamine—Vomiting—Dactinomycin—kidney cancer	9.33e-05	0.000464	CcSEcCtD
Galantamine—Bronchitis—Doxorubicin—kidney cancer	9.31e-05	0.000463	CcSEcCtD
Galantamine—Somnolence—Paclitaxel—kidney cancer	9.25e-05	0.00046	CcSEcCtD
Galantamine—Palpitations—Capecitabine—kidney cancer	9.25e-05	0.00046	CcSEcCtD
Galantamine—Rash—Dactinomycin—kidney cancer	9.25e-05	0.00046	CcSEcCtD
Galantamine—Nausea—Sunitinib—kidney cancer	9.2e-05	0.000457	CcSEcCtD
Galantamine—Loss of consciousness—Capecitabine—kidney cancer	9.2e-05	0.000457	CcSEcCtD
Galantamine—Dyspepsia—Paclitaxel—kidney cancer	9.16e-05	0.000455	CcSEcCtD
Galantamine—Cough—Capecitabine—kidney cancer	9.13e-05	0.000454	CcSEcCtD
Galantamine—Decreased appetite—Paclitaxel—kidney cancer	9.05e-05	0.00045	CcSEcCtD
Galantamine—Hypertension—Capecitabine—kidney cancer	9.04e-05	0.000449	CcSEcCtD
Galantamine—Upper respiratory tract infection—Doxorubicin—kidney cancer	9e-05	0.000447	CcSEcCtD
Galantamine—Gastrointestinal disorder—Paclitaxel—kidney cancer	8.99e-05	0.000447	CcSEcCtD
Galantamine—Fatigue—Paclitaxel—kidney cancer	8.98e-05	0.000446	CcSEcCtD
Galantamine—Diarrhoea—Vincristine—kidney cancer	8.97e-05	0.000446	CcSEcCtD
Galantamine—Pollakiuria—Doxorubicin—kidney cancer	8.95e-05	0.000445	CcSEcCtD
Galantamine—Asthenia—Gemcitabine—kidney cancer	8.92e-05	0.000443	CcSEcCtD
Galantamine—Arthralgia—Capecitabine—kidney cancer	8.91e-05	0.000443	CcSEcCtD
Galantamine—Chest pain—Capecitabine—kidney cancer	8.91e-05	0.000443	CcSEcCtD
Galantamine—Myalgia—Capecitabine—kidney cancer	8.91e-05	0.000443	CcSEcCtD
Galantamine—Constipation—Paclitaxel—kidney cancer	8.9e-05	0.000442	CcSEcCtD
Galantamine—Anxiety—Capecitabine—kidney cancer	8.88e-05	0.000441	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	8.85e-05	0.00044	CcSEcCtD
Galantamine—Discomfort—Capecitabine—kidney cancer	8.81e-05	0.000438	CcSEcCtD
Galantamine—Weight decreased—Doxorubicin—kidney cancer	8.76e-05	0.000435	CcSEcCtD
Galantamine—Hyperglycaemia—Doxorubicin—kidney cancer	8.74e-05	0.000434	CcSEcCtD
Galantamine—Dry mouth—Capecitabine—kidney cancer	8.72e-05	0.000433	CcSEcCtD
Galantamine—Nausea—Dactinomycin—kidney cancer	8.71e-05	0.000433	CcSEcCtD
Galantamine—Pneumonia—Doxorubicin—kidney cancer	8.68e-05	0.000432	CcSEcCtD
Galantamine—Dizziness—Vincristine—kidney cancer	8.67e-05	0.000431	CcSEcCtD
Galantamine—Confusional state—Capecitabine—kidney cancer	8.61e-05	0.000428	CcSEcCtD
Galantamine—Feeling abnormal—Paclitaxel—kidney cancer	8.58e-05	0.000426	CcSEcCtD
Galantamine—Gastrointestinal pain—Paclitaxel—kidney cancer	8.51e-05	0.000423	CcSEcCtD
Galantamine—Diarrhoea—Gemcitabine—kidney cancer	8.51e-05	0.000423	CcSEcCtD
Galantamine—Renal failure—Doxorubicin—kidney cancer	8.49e-05	0.000422	CcSEcCtD
Galantamine—Neuropathy peripheral—Doxorubicin—kidney cancer	8.46e-05	0.000421	CcSEcCtD
Galantamine—Shock—Capecitabine—kidney cancer	8.41e-05	0.000418	CcSEcCtD
Galantamine—Urinary tract infection—Doxorubicin—kidney cancer	8.39e-05	0.000417	CcSEcCtD
Galantamine—Nervous system disorder—Capecitabine—kidney cancer	8.38e-05	0.000416	CcSEcCtD
Galantamine—Thrombocytopenia—Capecitabine—kidney cancer	8.36e-05	0.000416	CcSEcCtD
Galantamine—Tachycardia—Capecitabine—kidney cancer	8.34e-05	0.000414	CcSEcCtD
Galantamine—Vomiting—Vincristine—kidney cancer	8.33e-05	0.000414	CcSEcCtD
Galantamine—Skin disorder—Capecitabine—kidney cancer	8.3e-05	0.000412	CcSEcCtD
Galantamine—Rash—Vincristine—kidney cancer	8.26e-05	0.000411	CcSEcCtD
Galantamine—Hyperhidrosis—Capecitabine—kidney cancer	8.26e-05	0.00041	CcSEcCtD
Galantamine—Dermatitis—Vincristine—kidney cancer	8.26e-05	0.00041	CcSEcCtD
Galantamine—Haematuria—Doxorubicin—kidney cancer	8.23e-05	0.000409	CcSEcCtD
Galantamine—Abdominal pain—Paclitaxel—kidney cancer	8.23e-05	0.000409	CcSEcCtD
Galantamine—Body temperature increased—Paclitaxel—kidney cancer	8.23e-05	0.000409	CcSEcCtD
Galantamine—Headache—Vincristine—kidney cancer	8.21e-05	0.000408	CcSEcCtD
Galantamine—Hepatobiliary disease—Doxorubicin—kidney cancer	8.17e-05	0.000406	CcSEcCtD
Galantamine—Epistaxis—Doxorubicin—kidney cancer	8.14e-05	0.000405	CcSEcCtD
Galantamine—Anorexia—Capecitabine—kidney cancer	8.14e-05	0.000405	CcSEcCtD
Galantamine—Hypotension—Capecitabine—kidney cancer	7.98e-05	0.000397	CcSEcCtD
Galantamine—Vomiting—Gemcitabine—kidney cancer	7.91e-05	0.000393	CcSEcCtD
Galantamine—Bradycardia—Doxorubicin—kidney cancer	7.89e-05	0.000392	CcSEcCtD
Galantamine—Rash—Gemcitabine—kidney cancer	7.84e-05	0.00039	CcSEcCtD
Galantamine—Dermatitis—Gemcitabine—kidney cancer	7.83e-05	0.000389	CcSEcCtD
Galantamine—Haemoglobin—Doxorubicin—kidney cancer	7.79e-05	0.000387	CcSEcCtD
Galantamine—Headache—Gemcitabine—kidney cancer	7.79e-05	0.000387	CcSEcCtD
Galantamine—Nausea—Vincristine—kidney cancer	7.79e-05	0.000387	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.78e-05	0.000387	CcSEcCtD
Galantamine—Rhinitis—Doxorubicin—kidney cancer	7.77e-05	0.000386	CcSEcCtD
Galantamine—Haemorrhage—Doxorubicin—kidney cancer	7.75e-05	0.000385	CcSEcCtD
Galantamine—Hepatitis—Doxorubicin—kidney cancer	7.75e-05	0.000385	CcSEcCtD
Galantamine—Insomnia—Capecitabine—kidney cancer	7.73e-05	0.000384	CcSEcCtD
Galantamine—Paraesthesia—Capecitabine—kidney cancer	7.67e-05	0.000381	CcSEcCtD
Galantamine—Hypersensitivity—Paclitaxel—kidney cancer	7.67e-05	0.000381	CcSEcCtD
Galantamine—Urinary tract disorder—Doxorubicin—kidney cancer	7.65e-05	0.00038	CcSEcCtD
Galantamine—Oedema peripheral—Doxorubicin—kidney cancer	7.64e-05	0.000379	CcSEcCtD
Galantamine—Connective tissue disorder—Doxorubicin—kidney cancer	7.62e-05	0.000379	CcSEcCtD
Galantamine—Urethral disorder—Doxorubicin—kidney cancer	7.6e-05	0.000378	CcSEcCtD
Galantamine—Dyspepsia—Capecitabine—kidney cancer	7.52e-05	0.000374	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—kidney cancer	7.47e-05	0.000371	CcSEcCtD
Galantamine—Asthenia—Paclitaxel—kidney cancer	7.47e-05	0.000371	CcSEcCtD
Galantamine—Decreased appetite—Capecitabine—kidney cancer	7.43e-05	0.000369	CcSEcCtD
Galantamine—Nausea—Gemcitabine—kidney cancer	7.39e-05	0.000367	CcSEcCtD
Galantamine—Gastrointestinal disorder—Capecitabine—kidney cancer	7.38e-05	0.000367	CcSEcCtD
Galantamine—Fatigue—Capecitabine—kidney cancer	7.37e-05	0.000366	CcSEcCtD
Galantamine—Constipation—Capecitabine—kidney cancer	7.31e-05	0.000363	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—kidney cancer	7.24e-05	0.00036	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—kidney cancer	7.23e-05	0.000359	CcSEcCtD
Galantamine—Flushing—Doxorubicin—kidney cancer	7.19e-05	0.000357	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—kidney cancer	7.19e-05	0.000357	CcSEcCtD
Galantamine—Diarrhoea—Paclitaxel—kidney cancer	7.12e-05	0.000354	CcSEcCtD
Galantamine—Feeling abnormal—Capecitabine—kidney cancer	7.04e-05	0.00035	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—kidney cancer	7.03e-05	0.000349	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—kidney cancer	7e-05	0.000348	CcSEcCtD
Galantamine—Gastrointestinal pain—Capecitabine—kidney cancer	6.99e-05	0.000347	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—kidney cancer	6.92e-05	0.000344	CcSEcCtD
Galantamine—Dizziness—Paclitaxel—kidney cancer	6.88e-05	0.000342	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—kidney cancer	6.79e-05	0.000337	CcSEcCtD
Galantamine—Abdominal pain—Capecitabine—kidney cancer	6.75e-05	0.000336	CcSEcCtD
Galantamine—Body temperature increased—Capecitabine—kidney cancer	6.75e-05	0.000336	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—kidney cancer	6.75e-05	0.000335	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—kidney cancer	6.65e-05	0.00033	CcSEcCtD
Galantamine—Tension—Doxorubicin—kidney cancer	6.62e-05	0.000329	CcSEcCtD
Galantamine—Vomiting—Paclitaxel—kidney cancer	6.62e-05	0.000329	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—kidney cancer	6.61e-05	0.000328	CcSEcCtD
Galantamine—Rash—Paclitaxel—kidney cancer	6.56e-05	0.000326	CcSEcCtD
Galantamine—Dermatitis—Paclitaxel—kidney cancer	6.56e-05	0.000326	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—kidney cancer	6.55e-05	0.000326	CcSEcCtD
Galantamine—Back pain—Doxorubicin—kidney cancer	6.53e-05	0.000324	CcSEcCtD
Galantamine—Headache—Paclitaxel—kidney cancer	6.52e-05	0.000324	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—kidney cancer	6.49e-05	0.000322	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—kidney cancer	6.36e-05	0.000316	CcSEcCtD
Galantamine—Hypersensitivity—Capecitabine—kidney cancer	6.29e-05	0.000313	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—kidney cancer	6.26e-05	0.000311	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—kidney cancer	6.24e-05	0.00031	CcSEcCtD
Galantamine—Agitation—Doxorubicin—kidney cancer	6.2e-05	0.000308	CcSEcCtD
Galantamine—Nausea—Paclitaxel—kidney cancer	6.18e-05	0.000307	CcSEcCtD
Galantamine—Asthenia—Capecitabine—kidney cancer	6.13e-05	0.000305	CcSEcCtD
Galantamine—Malaise—Doxorubicin—kidney cancer	6.08e-05	0.000302	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—kidney cancer	6.06e-05	0.000301	CcSEcCtD
Galantamine—Syncope—Doxorubicin—kidney cancer	6.05e-05	0.000301	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—kidney cancer	5.96e-05	0.000296	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—kidney cancer	5.93e-05	0.000295	CcSEcCtD
Galantamine—Cough—Doxorubicin—kidney cancer	5.89e-05	0.000293	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—kidney cancer	5.85e-05	0.000291	CcSEcCtD
Galantamine—Diarrhoea—Capecitabine—kidney cancer	5.85e-05	0.00029	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—kidney cancer	5.83e-05	0.000289	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—kidney cancer	5.74e-05	0.000285	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—kidney cancer	5.74e-05	0.000285	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—kidney cancer	5.74e-05	0.000285	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—kidney cancer	5.72e-05	0.000284	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.71e-05	0.000284	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—kidney cancer	5.68e-05	0.000282	CcSEcCtD
Galantamine—Dizziness—Capecitabine—kidney cancer	5.65e-05	0.000281	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—kidney cancer	5.62e-05	0.000279	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—kidney cancer	5.55e-05	0.000276	CcSEcCtD
Galantamine—Vomiting—Capecitabine—kidney cancer	5.43e-05	0.00027	CcSEcCtD
Galantamine—Shock—Doxorubicin—kidney cancer	5.42e-05	0.000269	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—kidney cancer	5.4e-05	0.000268	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—kidney cancer	5.39e-05	0.000268	CcSEcCtD
Galantamine—Rash—Capecitabine—kidney cancer	5.39e-05	0.000268	CcSEcCtD
Galantamine—Dermatitis—Capecitabine—kidney cancer	5.38e-05	0.000267	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—kidney cancer	5.37e-05	0.000267	CcSEcCtD
Galantamine—Headache—Capecitabine—kidney cancer	5.35e-05	0.000266	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—kidney cancer	5.35e-05	0.000266	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—kidney cancer	5.32e-05	0.000265	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—kidney cancer	5.25e-05	0.000261	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—kidney cancer	5.15e-05	0.000256	CcSEcCtD
Galantamine—Nausea—Capecitabine—kidney cancer	5.07e-05	0.000252	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.02e-05	0.000249	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—kidney cancer	4.98e-05	0.000248	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—kidney cancer	4.94e-05	0.000246	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—kidney cancer	4.9e-05	0.000243	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—kidney cancer	4.85e-05	0.000241	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—kidney cancer	4.79e-05	0.000238	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.75e-05	0.000236	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—kidney cancer	4.75e-05	0.000236	CcSEcCtD
Galantamine—Constipation—Doxorubicin—kidney cancer	4.71e-05	0.000234	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—kidney cancer	4.54e-05	0.000226	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—kidney cancer	4.5e-05	0.000224	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—kidney cancer	4.35e-05	0.000216	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—kidney cancer	4.35e-05	0.000216	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—kidney cancer	4.06e-05	0.000202	CcSEcCtD
Galantamine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	3.97e-05	0.000808	CbGpPWpGaD
Galantamine—Asthenia—Doxorubicin—kidney cancer	3.95e-05	0.000196	CcSEcCtD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.94e-05	0.000802	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.93e-05	0.0008	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PDHB—kidney cancer	3.93e-05	0.0008	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.89e-05	0.000792	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—MAPK1—kidney cancer	3.79e-05	0.00077	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.79e-05	0.00077	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—RAF1—kidney cancer	3.77e-05	0.000767	CbGpPWpGaD
Galantamine—Diarrhoea—Doxorubicin—kidney cancer	3.77e-05	0.000187	CcSEcCtD
Galantamine—ACHE—Metabolism of proteins—MME—kidney cancer	3.77e-05	0.000766	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—RAF1—kidney cancer	3.73e-05	0.00076	CbGpPWpGaD
Galantamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.73e-05	0.000759	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.73e-05	0.000759	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CCBL1—kidney cancer	3.7e-05	0.000752	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—BRAF—kidney cancer	3.68e-05	0.000749	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	3.66e-05	0.000745	CbGpPWpGaD
Galantamine—Dizziness—Doxorubicin—kidney cancer	3.64e-05	0.000181	CcSEcCtD
Galantamine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	3.57e-05	0.000726	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.56e-05	0.000724	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—RAF1—kidney cancer	3.55e-05	0.000722	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.52e-05	0.000715	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PDHB—kidney cancer	3.51e-05	0.000713	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—RPL14—kidney cancer	3.5e-05	0.000712	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—HSPD1—kidney cancer	3.5e-05	0.000712	CbGpPWpGaD
Galantamine—Vomiting—Doxorubicin—kidney cancer	3.5e-05	0.000174	CcSEcCtD
Galantamine—Rash—Doxorubicin—kidney cancer	3.47e-05	0.000173	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—kidney cancer	3.47e-05	0.000172	CcSEcCtD
Galantamine—Headache—Doxorubicin—kidney cancer	3.45e-05	0.000171	CcSEcCtD
Galantamine—ACHE—Transmission across Chemical Synapses—BRAF—kidney cancer	3.43e-05	0.000698	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.38e-05	0.000687	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MME—kidney cancer	3.36e-05	0.000684	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	3.35e-05	0.000681	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.34e-05	0.00068	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CCBL1—kidney cancer	3.3e-05	0.000671	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.27e-05	0.000666	CbGpPWpGaD
Galantamine—Nausea—Doxorubicin—kidney cancer	3.27e-05	0.000163	CcSEcCtD
Galantamine—ACHE—Phospholipid metabolism—PTEN—kidney cancer	3.25e-05	0.000661	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.23e-05	0.000657	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GLIPR1—kidney cancer	3.21e-05	0.000652	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPAT—kidney cancer	3.21e-05	0.000652	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.18e-05	0.000646	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.16e-05	0.000644	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.13e-05	0.000637	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—HSPD1—kidney cancer	3.12e-05	0.000635	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—RPL14—kidney cancer	3.12e-05	0.000635	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—RAF1—kidney cancer	3.08e-05	0.000626	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—BRAF—kidney cancer	3.06e-05	0.000622	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.03e-05	0.000616	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—MAPK1—kidney cancer	3.01e-05	0.000613	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.98e-05	0.000607	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—MAPK1—kidney cancer	2.98e-05	0.000607	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APRT—kidney cancer	2.98e-05	0.000606	CbGpPWpGaD
Galantamine—ACHE—Metabolism—FH—kidney cancer	2.98e-05	0.000606	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.97e-05	0.000604	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.94e-05	0.000598	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.91e-05	0.000592	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PTEN—kidney cancer	2.9e-05	0.00059	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.87e-05	0.000585	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—RAF1—kidney cancer	2.86e-05	0.000583	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPAT—kidney cancer	2.86e-05	0.000582	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GLIPR1—kidney cancer	2.86e-05	0.000582	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—EIF4EBP1—kidney cancer	2.86e-05	0.000581	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.82e-05	0.000574	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GPC3—kidney cancer	2.8e-05	0.00057	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.79e-05	0.000568	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.75e-05	0.00056	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PAX6—kidney cancer	2.75e-05	0.000559	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CTSD—kidney cancer	2.73e-05	0.000556	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—MAPK1—kidney cancer	2.73e-05	0.000555	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CA2—kidney cancer	2.73e-05	0.000554	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.72e-05	0.000554	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APRT—kidney cancer	2.66e-05	0.000541	CbGpPWpGaD
Galantamine—BCHE—Metabolism—FH—kidney cancer	2.66e-05	0.000541	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALAD—kidney cancer	2.66e-05	0.00054	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.65e-05	0.00054	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—BRAF—kidney cancer	2.63e-05	0.000535	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.6e-05	0.000528	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ST3GAL2—kidney cancer	2.59e-05	0.000527	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.59e-05	0.000527	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—MAPK1—kidney cancer	2.59e-05	0.000526	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACHE—kidney cancer	2.58e-05	0.000524	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.57e-05	0.000523	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—MAPK1—kidney cancer	2.56e-05	0.000521	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	2.56e-05	0.00052	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	2.55e-05	0.000518	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALDH1A1—kidney cancer	2.53e-05	0.000515	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—BCHE—kidney cancer	2.52e-05	0.000512	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.51e-05	0.00051	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GPC3—kidney cancer	2.5e-05	0.000508	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	2.48e-05	0.000503	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PAX6—kidney cancer	2.45e-05	0.000499	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	2.44e-05	0.000496	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.44e-05	0.000496	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CTSD—kidney cancer	2.44e-05	0.000496	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—MAPK1—kidney cancer	2.43e-05	0.000495	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA2—kidney cancer	2.43e-05	0.000494	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PGK1—kidney cancer	2.43e-05	0.000494	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC5A3—kidney cancer	2.43e-05	0.000494	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LDHB—kidney cancer	2.38e-05	0.000484	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALAD—kidney cancer	2.37e-05	0.000482	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—BRAF—kidney cancer	2.34e-05	0.000477	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.33e-05	0.000475	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ST3GAL2—kidney cancer	2.31e-05	0.00047	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CA—kidney cancer	2.29e-05	0.000467	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	2.27e-05	0.000463	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.26e-05	0.000461	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDH1A1—kidney cancer	2.26e-05	0.00046	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	2.24e-05	0.000456	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—RAF1—kidney cancer	2.19e-05	0.000446	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.19e-05	0.000445	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PGK1—kidney cancer	2.17e-05	0.000441	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC5A3—kidney cancer	2.17e-05	0.000441	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	2.16e-05	0.000439	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.14e-05	0.000436	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	2.13e-05	0.000433	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LDHB—kidney cancer	2.13e-05	0.000432	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—MAPK1—kidney cancer	2.11e-05	0.000429	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.08e-05	0.000424	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CA9—kidney cancer	2.07e-05	0.00042	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	2.05e-05	0.000416	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.04e-05	0.000415	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.02e-05	0.000411	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.98e-05	0.000402	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.96e-05	0.0004	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—RAF1—kidney cancer	1.96e-05	0.000398	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF2—kidney cancer	1.95e-05	0.000396	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.93e-05	0.000392	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACY1—kidney cancer	1.9e-05	0.000386	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA9—kidney cancer	1.84e-05	0.000375	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.8e-05	0.000366	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.77e-05	0.00036	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CRABP1—kidney cancer	1.76e-05	0.000357	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.75e-05	0.000356	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF2—kidney cancer	1.74e-05	0.000353	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.71e-05	0.000348	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ITPR2—kidney cancer	1.63e-05	0.000332	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.62e-05	0.000329	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PDHB—kidney cancer	1.61e-05	0.000328	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—POMC—kidney cancer	1.61e-05	0.000327	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.6e-05	0.000325	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CRABP1—kidney cancer	1.57e-05	0.000319	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CCBL1—kidney cancer	1.52e-05	0.000308	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MAPK1—kidney cancer	1.51e-05	0.000306	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.51e-05	0.000306	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTT1—kidney cancer	1.49e-05	0.000303	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.49e-05	0.000302	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.47e-05	0.000298	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ITPR2—kidney cancer	1.46e-05	0.000296	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.41e-05	0.000287	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SCARB1—kidney cancer	1.41e-05	0.000287	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS1—kidney cancer	1.4e-05	0.000284	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.39e-05	0.000283	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PSMD7—kidney cancer	1.37e-05	0.000278	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MAPK1—kidney cancer	1.34e-05	0.000273	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.34e-05	0.000273	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ACHE—kidney cancer	1.33e-05	0.00027	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTT1—kidney cancer	1.33e-05	0.00027	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.31e-05	0.000267	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPAT—kidney cancer	1.31e-05	0.000267	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—POMC—kidney cancer	1.3e-05	0.000264	CbGpPWpGaD
Galantamine—ACHE—Metabolism—BCHE—kidney cancer	1.3e-05	0.000264	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC5A5—kidney cancer	1.28e-05	0.000261	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SCARB1—kidney cancer	1.26e-05	0.000256	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS1—kidney cancer	1.24e-05	0.000253	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACY1—kidney cancer	1.24e-05	0.000252	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC2A1—kidney cancer	1.24e-05	0.000252	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FH—kidney cancer	1.22e-05	0.000249	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APRT—kidney cancer	1.22e-05	0.000249	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PSMD7—kidney cancer	1.22e-05	0.000248	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.2e-05	0.000244	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—POMC—kidney cancer	1.16e-05	0.000236	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPC3—kidney cancer	1.15e-05	0.000234	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.000232	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA2—kidney cancer	1.12e-05	0.000227	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000224	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALAD—kidney cancer	1.09e-05	0.000222	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.07e-05	0.000218	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.06e-05	0.000216	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PDHB—kidney cancer	1.05e-05	0.000214	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.05e-05	0.000214	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.05e-05	0.000213	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.04e-05	0.000211	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—kidney cancer	1.03e-05	0.00021	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PGK1—kidney cancer	9.96e-06	0.000203	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC5A3—kidney cancer	9.96e-06	0.000203	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CCBL1—kidney cancer	9.91e-06	0.000202	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LDHB—kidney cancer	9.77e-06	0.000199	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCB1—kidney cancer	9.77e-06	0.000199	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—kidney cancer	9.48e-06	0.000193	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.34e-06	0.00019	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CTNNB1—kidney cancer	9.28e-06	0.000189	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—kidney cancer	9.21e-06	0.000187	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1A1—kidney cancer	8.99e-06	0.000183	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCB1—kidney cancer	8.71e-06	0.000177	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPAT—kidney cancer	8.6e-06	0.000175	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.6e-06	0.000175	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA9—kidney cancer	8.47e-06	0.000172	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—kidney cancer	8.46e-06	0.000172	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	8.28e-06	0.000168	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1A1—kidney cancer	8.02e-06	0.000163	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FH—kidney cancer	7.99e-06	0.000163	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APRT—kidney cancer	7.99e-06	0.000163	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPC3—kidney cancer	7.51e-06	0.000153	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.39e-06	0.00015	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA2—kidney cancer	7.31e-06	0.000149	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CRABP1—kidney cancer	7.2e-06	0.000146	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALAD—kidney cancer	7.12e-06	0.000145	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.95e-06	0.000141	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.79e-06	0.000138	CbGpPWpGaD
Galantamine—ACHE—Metabolism—POMC—kidney cancer	6.7e-06	0.000136	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ITPR2—kidney cancer	6.7e-06	0.000136	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.59e-06	0.000134	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PGK1—kidney cancer	6.51e-06	0.000132	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.51e-06	0.000132	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LDHB—kidney cancer	6.39e-06	0.00013	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACHE—kidney cancer	6.11e-06	0.000124	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—kidney cancer	6.11e-06	0.000124	CbGpPWpGaD
Galantamine—BCHE—Metabolism—POMC—kidney cancer	5.98e-06	0.000122	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SCARB1—kidney cancer	5.78e-06	0.000118	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS1—kidney cancer	5.72e-06	0.000116	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PSMD7—kidney cancer	5.61e-06	0.000114	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA9—kidney cancer	5.54e-06	0.000113	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—kidney cancer	5.35e-06	0.000109	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BCHE—kidney cancer	5.32e-06	0.000108	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC5A5—kidney cancer	5.25e-06	0.000107	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC2A1—kidney cancer	5.08e-06	0.000103	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—kidney cancer	4.77e-06	9.7e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CRABP1—kidney cancer	4.71e-06	9.58e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—kidney cancer	4.66e-06	9.48e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ITPR2—kidney cancer	4.38e-06	8.9e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—kidney cancer	4.23e-06	8.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—kidney cancer	4.16e-06	8.46e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCB1—kidney cancer	4.01e-06	8.15e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACHE—kidney cancer	3.99e-06	8.12e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—kidney cancer	3.99e-06	8.12e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—kidney cancer	3.89e-06	7.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.78e-06	7.69e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS1—kidney cancer	3.74e-06	7.61e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.69e-06	7.5e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PSMD7—kidney cancer	3.67e-06	7.46e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BCHE—kidney cancer	3.48e-06	7.07e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.44e-06	6.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.32e-06	6.75e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—kidney cancer	3.29e-06	6.69e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—kidney cancer	2.93e-06	5.97e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.77e-06	5.63e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—POMC—kidney cancer	2.75e-06	5.59e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.62e-06	5.33e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.54e-06	5.17e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.41e-06	4.9e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—kidney cancer	2.19e-06	4.46e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—kidney cancer	1.91e-06	3.89e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—POMC—kidney cancer	1.8e-06	3.66e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.43e-06	2.92e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.35e-06	2.74e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—kidney cancer	1.25e-06	2.54e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.82e-07	1.79e-05	CbGpPWpGaD
